Dominic Smethurst

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus et al. · Blood · 2013 · 1.2K citations

Life Sciences, Immunology, Oncology +16

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Z. Mark, Petr Zatloukal et al. · Journal of Clinical Oncology · 2011 · 244 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type <i>KRAS</i> Metastatic Colorectal Cancer

Eric Van Cutsem, Cathy Eng, Elżbieta Nowara et al. · Clinical Cancer Research · 2014 · 109 citations · Full text

Medicine, Oncology, Pharmacology +15

Are hospital waiting lists self-regulating?

Dominic Smethurst, Hywel C Williams · Nature · 2001 · 68 citations

Health Professions, Health Administration, Health Services Administration +10

First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study

George D. Demetri, Axel Le Cesne, Sant P. Chawla et al. · European Journal of Cancer · 2012 · 68 citations · Full text

Medicine, Oncology, Pharmacotherapy +14